ARCHIVE

• IMMD Completes PI Trial of IkB Kinase Inhibitor IMD-1041
  September 4, 2006

• Bribery Affairs in Relation to Clinical Trials Explained: Ihoken Seminar
  September 4, 2006

• R&D NEWS IN BRIEF
  September 4, 2006

• Nippon Chemiphar's GE Drug Sales Could Reach \100 Bil. in FY2006
  September 4, 2006

• Generics Account for 10.1% of Cost of Drugs in Non-legal Rx Issued by Clinics
  September 4, 2006

• SURVEY 4 articles
  September 4, 2006

• GENERIC NEWS IN BRIEF　Korosho's FY2007 Budget to Promote Use of GE Drugs
  September 4, 2006

• Eight APIs Recommended for Approval
  September 4, 2006

• 1/3 of Drug-Related Accidents Are Due to Wrong Dosage: JCQHC
  September 4, 2006

• RAPS to Initiate Training Program for Regulatory Affairs Professionals
  September 4, 2006

• Results of Two Studies Announced by JPA
  September 4, 2006

• Nichiiren to Support Mr Takemi in Next Election of Upper House
  September 4, 2006

• Next Medical Fee Revision "Won't Be Too Severe": Prof. Nishimura
  September 4, 2006

• REGULATORY NEWS IN BRIEF
  September 4, 2006

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  September 4, 2006

• Direct Deal between Makers, Med. Institutions Conditionally Approvable: Mr Katagiri of FTC
  September 4, 2006

• MEDICAL DEVICE NEWS IN BRIEF
  September 4, 2006

• Blopress Top-selling Drug in April-June: IMS Japan
  September 4, 2006

• SELF-MEDICATION NEWS IN BRIEF
  September 4, 2006

• Drug Wholesalers' Gross Profit Ratio Hits Record Low: FJPWA
  September 4, 2006

ページ

• « 先頭
• ‹ Prev
• …
• 385
• 386
• 387
• 388
• 389
• 390
• 391
• 392
• 393
• …
• Next ›
• 最終 »